Exir Pharmaceutical Distribution Co.
Exir Pharmaceutical Distribution Co. is an Iranian pharmaceutical distributor that sources products from 107 manufacturers and delivers 3,544 SKUs to 16,314+ pharmacies and healthcare centers across all 31 provinces via 21 regional distribution centers.
- Company typePrivate
- Founded2008
- HeadquartersTehran, Iran
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Exir Pharmaceutical Distribution Co. does
Exir Pharmaceutical Distribution Co. (شرکت پخش دارویی اکسیر) is an Iranian pharmaceutical distributor founded in 2008 and headquartered in Tehran, operating as a private subsidiary within the Tamin Pharmaceutical Investment Holding (TPIKO) ecosystem under the Social Security Investment Company. The company sources pharmaceutical, cosmetic, health, and medical equipment products from 107 manufacturers and distributes them to 16,314+ pharmacies and healthcare centers across all 31 Iranian provinces through 21 regional distribution centers and an equipped logistics fleet.
The company's technology stack centers on three core systems: a web-based Online Ordering System enabling pharmacies to place orders 24/7 directly with distribution centers and view real-time inventory; an Android-based Seller Ordering mobile application used by field sales representatives to capture and synchronize orders from pharmacy visits; and a Supplier Reporting portal allowing manufacturers to monitor distribution performance. These systems support a capillary distribution model in which field sales visits, online ordering, and direct delivery from regional warehouses combine to reach every Iranian province at uniform service standards compliant with the Food and Drug Organization's pharmaceutical distribution regulations.
Exir's revenue model is transaction-based: it purchases products from manufacturers and resells them to pharmacies and healthcare centers at a distribution margin embedded in product pricing, supplemented by logistics and warehousing services bundled into the distribution offering. The go-to-market is sales-led, combining a nationwide field sales force, a 24/7 self-serve ordering platform, and direct delivery from 21 regional centers. For fiscal year 1404 (ending March 2025/2026), the company reported operating revenue of 101,166 billion Iranian Rials (+47% YoY) and net profit of 2,705 billion Rials (+78% YoY), employing 700 staff and offering a portfolio of 3,544 product SKUs.
Exir Pharmaceutical Distribution Co. firmographics
Firmographics- Name
- Exir Pharmaceutical Distribution Co.
- Legal name
- Exir Pharmaceutical Distribution Co. (شرکت پخش دارویی اکسیر)
- Website
- https://exirpd.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Exir Pharmaceutical Distribution Co. is an Iranian pharmaceutical distributor that sources products from 107 manufacturers and delivers 3,544 SKUs to 16,314+ pharmacies and healthcare centers across all 31 provinces via 21 regional distribution centers.
- Ownership category
- akta.pro rank
Exir Pharmaceutical Distribution Co. industry classification
Industry- Product category
- Pharmaceutical Distribution Services
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Full-Line Pharmaceutical Wholesalers (HLAIAJAA)
- akta.pro secondary industries
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Specialty Pharmaceutical Distributors (HLAIAJAB)
Keywords
Where Exir Pharmaceutical Distribution Co. is headquartered
LocationHeadquarters
- HQ city
- Tehran
- HQ country
- Iran
- HQ region
- Middle East
Offices22 records
Markets served
Exir Pharmaceutical Distribution Co. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Distribution: The company operates as a pharmaceutical distributor purchasing products from pharmaceutical manufacturers (107+ suppliers) and selling/distributing them to pharmacies and healthcare centers across Iran. Revenue is generated through the markup/spread between purchase and sale prices across the distribution network.
- Logistics and Warehousing Services: The company provides equipped distribution fleet and modern warehousing services as part of its core distribution offering, supporting capillary distribution to all provinces. Revenue derives from the distribution margin built into product pricing.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Exir Pharmaceutical Distribution Co. product offering
Product offeringCore offering
Exir Pharmaceutical Distribution Co. purchases pharmaceutical, cosmetic, health, and medical equipment products from 107 manufacturers and distributes them through 21 regional distribution centers to 16,314+ pharmacies and healthcare centers across all provinces of Iran. The company operates a capillary B2B distribution model with owned logistics fleet, modern warehousing, a web-based 24/7 online ordering platform, a field sales mobile application, and a supplier reporting portal, all in compliance with Iran's Food and Drug Organization standards.
Product overview
Exir Pharmaceutical Distribution Co. operates as a pharmaceutical distribution company with 21 distribution centers across Iran, serving over 16,314 pharmacy and healthcare customers with a portfolio of 3,544 pharmaceutical products from 107 suppliers. The company offers a web-based online ordering system (Online Ordering System) enabling pharmacies to place orders 24/7, a Seller Ordering Mobile Application for field sales representatives, and an Online Supplier Reporting portal for pharmaceutical manufacturers to monitor their distribution performance. These systems collectively support the company's nationwide capillary distribution network, which operates according to Food and Drug Organization standards. The company is part of the Tamin Social Security Investment Company (TPIICO) holding and leverages an equipped logistics fleet for timely drug delivery across all Iranian provinces.
Differentiator
Problem solved
Functional benefit
Products and services
- Online Ordering System (سفارش گیری آنلاین اکسیر) Web-based ordering system that allows licensed pharmacies to place pharmaceutical, cosmetic, health, and medical equipment orders 24/7, view real-time inventory, track order status, and manage procurement directly with Exir's 21 regional distribution centers without requiring physical visits or sales representatives.
- Online Supplier Reporting (گزارش تامین کنندگان) Web-based supplier reporting portal that enables pharmaceutical manufacturers and importers to monitor their orders, deliveries, and inventory status through Exir's nationwide distribution network.
- Seller Ordering Mobile Application (نرم افزار سفارش گیری فروشنده) Android-based mobile application provided to Exir's field sales representatives for order-taking on tablets, enabling real-time order submission, delivery tracking, and inventory updates while visiting pharmacies and healthcare facilities.
- Pharmaceutical, Cosmetic, Health and Medical Equipment Distribution Capillary B2B distribution of 3,544 pharmaceutical, cosmetic, health, and medical equipment products sourced from 107 manufacturers to 16,314+ pharmacies and healthcare centers across all Iranian provinces via 21 regional distribution centers and an owned logistics fleet, compliant with Iran's Food and Drug Organization standards.
- Logistics and Warehousing Services Equipped logistics fleet and modern warehousing infrastructure supporting capillary distribution of pharmaceutical products across all provinces of Iran, including central warehouses in Tehran and 21 regional distribution centers.
Quantifiable outcome
- 47% growth in operating revenue to 101,166 billion Rials in fiscal year 1404
- +1 more outcomes
Companies that use Exir Pharmaceutical Distribution Co.
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles3 records
Exir Pharmaceutical Distribution Co. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Exir Pharmaceutical Distribution Co. partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- 107 Pharmaceutical Manufacturers (تامینکنندگان)coreExir sources pharmaceutical, cosmetics, health, and medical equipment products from 107 pharmaceutical manufacturers including: Daroukhane Azad Iran, Kharazmi, Osveh, Dana, SinaGen, Ariaogen, Novita Vision, Nano Alvand, Sina Darou, Beestan Darou, Alvand, Jalin, Razi, Shafa, Alhavi, Alborz, Caspian Tamin, Farabi, Aboureihan, and others. The company conducts synergy meetings with key suppliers such as Caspian Tamin to optimize the supply chain.
- Food and Drug Organization of Iran (سازمان غذا و دارو)coreExir Pharmaceutical Distribution Co. operates as a licensed pharmaceutical distributor under the supervision of Iran's Ministry of Health, Treatment, and Medical Education, specifically the Food and Drug Organization (FDA). The company maintains compliance with FDA pharmaceutical distribution standards across all 21 distribution centers.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Exir Pharmaceutical Distribution Co. competitors and assessment
Company assessmentBroad incumbents
- Sinopharm Group: China's largest pharmaceutical distributor and state-affiliated healthcare conglomerate. Comparable as a large, state-affiliated pharma distribution and supply chain operator with nationwide capillary reach in a regulated market.
- Tamin Pharmaceutical Investment Holding (TPIKO): Parent holding company of Exir and the broader pharmaceutical distribution/production conglomerate under Social Security Investment Co. Operates multiple distribution and manufacturing subsidiaries across Iran; comparable umbrella player in the same regulated channel.
- McKesson Corporation: Global pharmaceutical distributor (large incumbent) providing full-line Rx wholesale, distribution technology, and supply chain services. Comparable as a large-scale pharma distribution benchmark, though operating in heavily regulated US/European markets.
Regional players
- SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Leading Saudi pharmaceutical distribution and manufacturing company with capillary networks across MENA. Comparable in regulated pharmaceutical distribution model and pharmacy-centric customer base, though geographically distinct.
- Caspian Tamin Pharmaceutical Co. Iranian pharmaceutical manufacturer and distributor; while Tamin-affiliated, it operates production plus distribution, overlapping with Exir's distribution function and serving as both supplier and adjacent peer.
- Julphar (Gulf Pharmaceutical Industries): MENA-based pharmaceutical manufacturer and distributor with operations in Iran and other MENA markets. Comparable in regulatory-driven pharmaceutical distribution, though serves a broader regional footprint.
Direct peers
- Tehran Darou Pharmaceutical Distribution Co. Iranian full-line pharmaceutical wholesaler providing distribution to pharmacies. Comparable in offering scope, customer profile, and regulatory positioning in Iran's pharmaceutical supply chain.
- Hakim Darou Pharmaceutical Distribution Co. Iranian pharmaceutical distributor serving pharmacies and healthcare centers with comparable capillary distribution model and FDA license. Direct competitor in Iranian Rx wholesale distribution.
- Darou Pakhsh Holding Company: Iran's largest pharmaceutical distribution holding, of which Exir holds a 19.7% stake. Directly comparable: full-line pharmaceutical wholesaler serving pharmacies across Iran with similar regulatory FDA licensing and capillary distribution.
- Shafa Darou Pharmaceutical Distribution Co. Iranian pharmaceutical wholesaler distributing Rx and OTC products to pharmacies nationwide; directly comparable to Exir in product mix, customer base, and FDA-licensed distribution model.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Exir Pharmaceutical Distribution Co. social profiles
Digital presenceExir Pharmaceutical Distribution Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exir Pharmaceutical Distribution Co. leadership team
Management profileNumber of profiles
Profiles25 records
Exir Pharmaceutical Distribution Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exir Pharmaceutical Distribution Co. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exir Pharmaceutical Distribution Co.
What does Exir Pharmaceutical Distribution Co. do?
Exir Pharmaceutical Distribution Co. purchases pharmaceutical, cosmetic, health, and medical equipment products from 107 manufacturers and distributes them through 21 regional distribution centers to 16,314+ pharmacies and healthcare centers across all provinces of Iran. The company operates a capillary B2B distribution model with owned logistics fleet, modern warehousing, a web-based 24/7 online ordering platform, a field sales mobile application, and a supplier reporting portal, all in compliance with Iran's Food and Drug Organization standards.
Is Exir Pharmaceutical Distribution Co. a public or private company?
Exir Pharmaceutical Distribution Co. is a private company. It is classified as corporate owned and is currently operating.
When was Exir Pharmaceutical Distribution Co. founded?
Exir Pharmaceutical Distribution Co. was founded in 2008. It employs 101 to 250 people.
Where is Exir Pharmaceutical Distribution Co. based?
Exir Pharmaceutical Distribution Co. is headquartered in Tehran, Iran, in the Middle East region.
How does Exir Pharmaceutical Distribution Co. make money?
Two revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are logistics and Warehousing Services.
Who are Exir Pharmaceutical Distribution Co.'s main competitors?
Broad incumbents on record are Sinopharm Group, Tamin Pharmaceutical Investment Holding (TPIKO) and McKesson Corporation. Regional players are SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances), Caspian Tamin Pharmaceutical Co. and Julphar (Gulf Pharmaceutical Industries). Direct peers are Tehran Darou Pharmaceutical Distribution Co., Hakim Darou Pharmaceutical Distribution Co., Darou Pakhsh Holding Company and Shafa Darou Pharmaceutical Distribution Co..
Does Exir Pharmaceutical Distribution Co. have an API?
No public API is recorded for Exir Pharmaceutical Distribution Co..
What industry is Exir Pharmaceutical Distribution Co. in?
Exir Pharmaceutical Distribution Co.'s product category is Pharmaceutical Distribution Services. Its primary akta.pro industry code is HLAIAJAA, Full-Line Pharmaceutical Wholesalers, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 424210 and its SIC code is 5122.